A highly efficient protocol of generating and analyzing VZV ORF deletion mutants based on a newly developed luciferase VZV BAC system

Journal of Virological Methods

Volumn 148, Issue 1-2, 2008, Pages 197-204

  Zhang, Zhen ^a   Huang, Ying ^a   Zhu, Hua ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Bacterial artificial chromosome; Bioluminescence; Deletion mutagenesis; Varicella Zoster Virus

Indexed keywords

LUCIFERASE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BIOLUMINESCENCE; CELL CULTURE; CONTROLLED STUDY; GENE DELETION; GROWTH CURVE; HUMAN; HUMAN CELL; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VARICELLA ZOSTER VIRUS; VIRUS ISOLATION;

CELL LINE; CHROMOSOMES, ARTIFICIAL, BACTERIAL; GENE DELETION; GENES, REPORTER; GENES, VIRAL; HERPESVIRUS 3, HUMAN; HUMANS; LUCIFERASES, FIREFLY; MOLECULAR BIOLOGY; PLAQUE ASSAY; VIROLOGY;

BACTERIA (MICROORGANISMS); HERPES ZOSTER; HERPESVIRIDAE; HUMAN HERPESVIRUS 3;

EID: 39149094279     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2007.11.012     Document Type: Article

References (11)

1. Abendroth A., and Arvin A. Varicella-zoster virus immune evasion. Immunol. Rev. 168 (1999) 143-156
2. Cohen J.I., and Seidel K.E. Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 7376-7380
3. Cohen J.I., Krogmann T., Ross J.P., Pesnicak L., and Prikhod'ko E.A. Varicella-zoster virus ORF4 latency-associated protein is important for establishment of latency. J. Virol. 79 (2005) 6969-6975
4. Cohen J.I., Straus S.E., and Arvin A.M. Varicella-zoster virus replication, pathogenesis, and management. In: Knipe D.M., and Howley P.M. (Eds). Fields Virology vol. 2 (2007), Lippincott Williams & Wilkins, Philadelphia, PA 2773-2818
5. Nagaike K., Mori Y., Gomi Y., Yoshii H., Takahashi M., Wagner M., Koszinowski U., and Yamanishi K. Cloning of the varicella-zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli. Vaccine 22 (2004) 4069-4074
6. Netterwald J., Yang S., Wang W., Ghanny S., Cody M., Soteropoulos P., Tian B., Dunn W., Liu F., and Zhu H. Two gamma interferon-activated site-like elements in the human cytomegalovirus major immediate-early promoter/enhancer are important for viral replication. J. Virol. 79 (2005) 5035-5046
7. Niizuma T., Zerboni L., Sommer M.H., Ito H., Hinchliffe S., and Arvin A.M. Construction of varicella-zoster virus recombinants from P-Oka cosmids and demonstration that ORF65 protein is dispensable for infection of human skin and T cells in the SCID-hu mouse model. J. Virol. 77 (2003) 6062-6065
8. Sato B., Sommer M., Ito H., and Arvin A.M. Requirement of varicella-zoster virus immediate-early 4 protein for viral replication. J. Virol. 77 (2003) 12369-12372
9. Wang W., Patterson C.E., Yang S., and Zhu H. Coupling generation of cytomegalovirus deletion mutants and amplification of viral BAC clones. J. Virol. Methods 121 (2004) 137-143
10. Yu D., Ellis H.M., Lee E.C., Jenkins N.A., Copeland N.G., and Court D.L. An efficient recombination system for chromosome engineering in Escherichia coli. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 5978-5983
11. Zhang Z., Rowe J., Wang W., Sommer M., Arvin A., Moffat J., and Zhu H. Genetic analysis of varicella zoster virus ORF0 to 4 using a novel luciferase bacterial artificial chromosome system. J. Virol. 81 (2007) 9024-9033